Company / PP&E (Net)
AETHLON MEDICAL INC PP&E (Net) History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.0M
FY2024
5-year range
$140.5K / $1.1M
FY2020-FY2024
Trend
-11.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $441,238 to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2024 with a 10-year CAGR of +28.3%.
Improved from $441,238 to $1M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +84.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- +28.3%
Key checks
Key Insights
- 3-year CAGR of +84.8%, indicating consistent growth.
- In FY2024, pp&e (net) decreased 11.3% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.0M | -11.3% |
| FY2023 | $1.1M | +159.3% |
| FY2022 | $441.2K | +174.1% |
| FY2021 | $161.0K | +14.6% |
| FY2020 | $140.5K | +409.9% |
| FY2018 | $27.6K | -5.7% |
| FY2017 | $29.2K | -18.9% |
| FY2016 | $36.0K | -35.8% |
| FY2015 | $56.1K | -33.4% |
| FY2014 | $84.3K | +58023.4% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026